retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial results Retatrutide, a GIP, and receptor agonist Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

If sleep troubles continue past the adaptation period, talking to a doctor becomes important

Ook wordt er gewerkt aan pillen in plaats van injecties

Petersen KF, Shulman GI

[10] Conversely, starting or stopping thyroid hormone replacement could alter the growth hormone response

The primary limitations identified included the absence of a list of excluded studies and justification, as well as a written or registered protocol for the included studies, a lack of detailed funding sources, an assessment of risk of bias, and a discussion regarding the heterogeneity observed

There hasnt been a breakthrough in medications with such tremendous public health relevance related to chronic disease prevention since the advent of statins in 1986, which revolutionized treatment of high cholesterol, and protease inhibitors in 1996, which turned HIV from a death sentence to a chronic, manageable illness